Literature DB >> 10599782

Prevalence of epilepsy in rural Bolivia: a door-to-door survey.

A Nicoletti1, A Reggio, A Bartoloni, G Failla, V Sofia, F Bartalesi, M Roselli, H Gamboa, E Salazar, R Osinaga, F Paradisi, G Tempera, M Dumas, A J Hall.   

Abstract

OBJECTIVE: To carry out a door-to-door survey in rural areas of the Cordillera Province, Santa Cruz Department, Bolivia, to determine the prevalence of neurologic diseases (epilepsy, stroke, parkinsonism, and peripheral neuropathy) in a sample of approximately 10,000 inhabitants.
METHODS: A team of nondoctor health workers administered a standard screening instrument for neurologic diseases-a slightly modified version of the World Health Organization protocol. All subjects found positive during the screening underwent a neurologic examination.
RESULTS: On screening, the authors found 1,130 positive subjects, of whom 1,027 were then investigated by neurologists. On the basis of the definition proposed by the International League Against Epilepsy, we detected 124 epileptic patients (prevalence, 12.3/1,000), 112 of whom had active epilepsy (prevalence, 11.1/1,000) on the prevalence day (November 1, 1994). Peak age-specific prevalence occurred in the 15 to 24-year age group (20.4/1,000). Sex-specific prevalence was higher in women (13.1/1,000) than men (11.4/1,000). Eighty-nine patients (71.8%) underwent a standard EEG recording. Considering both EEG and clinical data, partial seizures were the most common type (53.2%) based on the classification of the International League Against Epilepsy. The mean age at onset was 20.7 years for partial seizures and 13.6 years for generalized seizures. Only 10.5% of patients had received specific treatment for more than 2 months of their life.
CONCLUSION: This report on epilepsy prevalence in Bolivia confirms that epilepsy is a major health problem in rural areas of developing countries.

Entities:  

Mesh:

Year:  1999        PMID: 10599782     DOI: 10.1212/wnl.53.9.2064

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Global disparities in the epilepsy treatment gap: a systematic review.

Authors:  Ana-Claire Meyer; Tarun Dua; Juliana Ma; Shekhar Saxena; Gretchen Birbeck
Journal:  Bull World Health Organ       Date:  2009-09-25       Impact factor: 9.408

2.  A locus for juvenile myoclonic epilepsy maps to 2q33-q36.

Authors:  Rinki Ratnapriya; Joseph Vijai; Jayaram S Kadandale; Rajesh S Iyer; Kurupath Radhakrishnan; Anuranjan Anand
Journal:  Hum Genet       Date:  2010-05-14       Impact factor: 4.132

Review 3.  The descriptive epidemiology of epilepsy-a review.

Authors:  Poonam Nina Banerjee; David Filippi; W Allen Hauser
Journal:  Epilepsy Res       Date:  2009-04-15       Impact factor: 3.045

4.  High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.

Authors:  Laura E Hernández-Vanegas; Aurelio Jara-Prado; Adriana Ochoa; Nayelli Rodríguez Y Rodríguez; Reyna M Durón; Daniel Crail-Meléndez; Ma Elisa Alonso; Antonio V Delgado-Escueta; Iris E Martínez-Juárez
Journal:  Epilepsy Behav       Date:  2016-06-11       Impact factor: 2.937

5.  Efhc1 deficiency causes spontaneous myoclonus and increased seizure susceptibility.

Authors:  Toshimitsu Suzuki; Hiroyuki Miyamoto; Takashi Nakahari; Ikuyo Inoue; Takahiro Suemoto; Bin Jiang; Yuki Hirota; Shigeyoshi Itohara; Takaomi C Saido; Tadaharu Tsumoto; Kazunobu Sawamoto; Takao K Hensch; Antonio V Delgado-Escueta; Kazuhiro Yamakawa
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

6.  Validation of a brief screening instrument for the ascertainment of epilepsy.

Authors:  Ruth Ottman; Christie Barker-Cummings; Cynthia L Leibson; Vincent M Vasoli; W Allen Hauser; Jeffrey R Buchhalter
Journal:  Epilepsia       Date:  2009-08-19       Impact factor: 5.864

7.  Prevalence of active convulsive epilepsy in an urban slum in Enugu South East Nigeria.

Authors:  Birinus Adikaibe Ezeala-Adikaibe; Casmir Orjioke; Oluchi Ekenze; Uchenna Ijoma; Obinna Onodugo; Orakwue Molokwu; Peter Chime; Nkiru Mbadiwe; Eddy Aneke; Chinwe Onyekonwu; Grace Okudo; Celestine Okwara; Godwin Onyebueke; Ifeoma Ulasi
Journal:  Seizure       Date:  2016-01-07       Impact factor: 3.184

8.  Advances in genetics of juvenile myoclonic epilepsies.

Authors:  Antonio V Delgado-Escueta
Journal:  Epilepsy Curr       Date:  2007 May-Jun       Impact factor: 7.500

Review 9.  The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies.

Authors:  Caroline K Mbuba; Anthony K Ngugi; Charles R Newton; Julie A Carter
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

10.  EFHC1 variants in juvenile myoclonic epilepsy: reanalysis according to NHGRI and ACMG guidelines for assigning disease causality.

Authors:  Julia N Bailey; Christopher Patterson; Laurence de Nijs; Reyna M Durón; Viet-Huong Nguyen; Miyabi Tanaka; Marco T Medina; Aurelio Jara-Prado; Iris E Martínez-Juárez; Adriana Ochoa; Yolli Molina; Toshimitsu Suzuki; María E Alonso; Jenny E Wight; Yu-Chen Lin; Laura Guilhoto; Elza Marcia Targas Yacubian; Jesús Machado-Salas; Andrea Daga; Kazuhiro Yamakawa; Thierry M Grisar; Bernard Lakaye; Antonio V Delgado-Escueta
Journal:  Genet Med       Date:  2016-07-28       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.